Filing Details

Accession Number:
0001562180-15-000660
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-11 11:21:51
Reporting Period:
2015-08-10
Filing Date:
2015-08-11
Accepted Time:
2015-08-11 11:21:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597553 Sage Therapeutics Inc. SAGE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612903 Thomas Anderson C/O Sage Therapeutics, Inc.
215 First Street
Cambridge MA 02142
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-08-10 3,480 $67.66 2,520 No 4 S Direct
Common Stock Disposition 2015-08-10 1,220 $67.14 1,300 No 4 S Direct
Common Stock Disposition 2015-08-10 1,300 $65.34 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. This transaction was executed in multiple trades at prices ranging from $67.29 USD to $68.29 USD. The price reported above reflects the weighted average sale price.
  3. This transaction was executed in multiple trades at prices ranging from $67.045 USD to $67.28 USD. The price reported above reflects the weighted average sale price.
  4. This transaction was executed in multiple trades at prices ranging from $65.21 USD to $66.20 USD. The price reported above reflects the weighted average sale price.